The anonymous guest in this interview has previously worked alongside Health Canada for pharmaceutical regulation and review as it pertains to marketing and pricing of market drugs. She holds a Doctor of Pharmacy and Bachelor of Science in Pharmacy, and together we dissect the recent British Medical Journal whistleblower publication regarding regulatory misconduct at the lab in Texas responsible for conducting one of Pfizer’s clinical trials.
FULL REPORT from Tamara Ugolini: https://rebelne.ws/3o1OQvL
